Is it finally time to buy these beaten-down FTSE 100 stocks?

These two FTSE 100 (INDEXFTSE: UKX) stocks have sunk recently. Is now the time to pile in?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While investor appetite for Sage Group (LSE: SGE) has snapped to three-month highs in recent sessions, the stock remains some way off the record peaks of around 760p struck last October.

Indeed, the business software specialist is dealing at a 13% discount to the lofty levels seen last autumn. And I believe this provides a great opportunity for dip buyers to get in on the FTSE 100 star.

Stock pickers took flight in autumn as fears of an intensifying sales slowdown took hold, concerns that were given additional fuel following January’s trading statement for the first fiscal quarter. Sage advised back then that organic sales rose 5.1% during September-December, cooling from the 6.6% advance punched in the corresponding 2015 period.

However, those pressing the panic button could be seen as acting somewhat prematurely. After all, chief financial officer Steve Hare commented in January that “Q1 results are broadly in line with our expectations,” affirming Sage’s view that “the early part of FY17 would start more slowly, with growth accelerating through the year and into FY18.”

The company remains on track to achieve robust full-year revenue growth of 6%, Hare added.

Growth great

City brokers certainly expect sales at Sage to keep strolling higher, and in turn deliver earnings rises of 17% in the year to September 2017 and 9% in fiscal 2018.

While a forward P/E ratio may ride above the FTSE 100 historical average of 15 times, this is still great value as the move to a subscription-based product structure gathers pace and each of the company’s major territories (aside from the US) either performs in line or exceeds forecasts. Indeed, Sage saw subscription sales rocket 31% higher during the first fiscal quarter.

On top of this, I also believe its terrific cash generation makes it one of the Footsie’s hottest growth dividend stocks. The company registered robust free cash flow of £254m last year, facilitating an 8% full-year dividend hike.

And the Square Mile expects this uptrend to continue, with last year’s payout of 14.15p per share anticipated to rise to 15.7p in this fiscal period and to 17.4p in 2018. These projections yield a handy-if-unspectacular 2.4% and 2.6% respectively.

In a hole

Like Sage, Anglo American (LSE: AAL) has been no stranger to extreme share price weakness more recently as fears over the iron ore market have resurfaced.

The mining giant’s share price has slipped 15% from the two-and-a-half-year peaks struck in February. And I reckon more trouble could be in store as Chinese inventories steadily bulge, casting doubts over whether domestic demand is strong enough to suck up the growing amount of seaborne supply.

The City still believes Anglo American should keep its growth recovery rolling with a 32% advance in 2017. But a predicted 26% decline next year underlines the shaky footing the company — nay, the entire mining industry — currently finds itself on as supply/demand balances worsen.

So while Anglo American may appear terrific value on paper, the business boasting a prospective earnings multiple of 6.4 times, I reckon the digger remains an unappealing pick for shrewd investors.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended Sage Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

Up 12% today, here’s a great FTSE 250 growth share to consider!

Softcat's share price is soaring following a blockbuster first-half trading announcement. Here's why the FTSE 250 share is worth a…

Read more »

Growth Shares

Prediction: in 1 year, the easyJet share price could be as high as…

Jon Smith points out why the easyJet share price could head higher over the coming year based on the current…

Read more »

Investing Articles

Up 21% with dividends on top! See the stunning Shell share price forecast for 2025

Brokers are feeling optimistic about the outlook for the Shell share price, predicting solid growth this year. But Harvey Jones…

Read more »

Investing Articles

£10,000 invested in AstraZeneca shares 1 year ago is now worth…

AstraZeneca shares have recovered from their brief slump with investors broadly buoyed by the company’s long-term business prospects.

Read more »

Investing Articles

What’s going on with Nvidia stock?

Nvidia stock has slumped, and it seems that CEO Jensen Huang may have lost the Midas touch after his AI…

Read more »

Investing For Beginners

Starting at 46, how much would need to be invested in the FTSE 100 to have £445k by retirement?

Jon Smith provides a rundown of the strategy, specific ideas and the numbers involved to grow a FTSE 100 portfolio…

Read more »

Investing Articles

3 top AIM stocks to consider buying before they recover

AIM stocks aren't for faint-hearted investors. But here are three high-quality examples for the risk-tolerant to ponder buying while they're…

Read more »

Black father and two young daughters dancing at home
Investing Articles

The M&G share price soars 5% as it raises its dividend outlook despite £1.9bn in outflows

The M&G share price was given a boost this morning after its full-year results revealed a progressive dividend policy. Our…

Read more »